Skip to main content
Top
Published in: BMC Infectious Diseases 1/2020

Open Access 01-12-2020 | Septicemia | Research article

Sepsis in cancer patients residing in Zimbabwe: spectrum of bacterial and fungal aetiologies and their antimicrobial susceptibility patterns

Authors: Frank Chinowaita, Wendy Chaka, Tinashe K. Nyazika, Tendai C. Maboreke, Emmanuel Tizauone, Prichard Mapondera, Inam Chitsike, Andrew Z. Cakana, Rooyen T. Mavenyengwa

Published in: BMC Infectious Diseases | Issue 1/2020

Login to get access

Abstract

Background

Cancer and sepsis comorbidity is a major public health problem in most parts of the world including Zimbabwe. The microbial aetiologies of sepsis and their antibiograms vary with time and locations. Knowledge on local microbial aetiologies of sepsis and their susceptibility patterns is critical in guiding empirical antimicrobial treatment choices.

Methods

This was a descriptive cross-sectional study which determined the microbial aetiologies of sepsis from blood cultures of paediatric and adult cancer patients obtained between July 2016 and June 2017. The TDR-X120 blood culture system and TDR 300B auto identification machine were used for incubation of blood culture bottles and identification plus antimicrobial susceptibility testing, respectively.

Results

A total of 142 participants were enrolled; 50 (35.2%) had positive blood cultures, with 56.0% Gram positive, 42.0% Gram-negative bacteria and 2.0% yeast isolated. Common species isolated included coagulase negative Staphylococcus spp. (CoNS) (22.0%), E. coli (16.0%), K. pneumoniae (14.0%), E. faecalis (14.0%) and S. aureus (8.0%). Gram-negative isolates exhibited high resistance to gentamicin (61.9%) and ceftriaxone (71.4%) which are the empiric antimicrobial agents used in our setting. Amikacin and meropenem showed 85.7 and 95.2% activity respectively against all Gram-negative isolates, whilst vancomycin and linezolid were effective against 96.2 and 100.0% of all Gram-positive isolates respectively. We isolated 10 (66.7%) extended spectrum β-lactamase (ESBL) amongst the E. coli and K. pneumoniae isolates. Ten (66.7%) of the Staphylococcus spp. were methicillin resistant.

Conclusions

CoNS, E. coli, K. pneumoniae, E. faecalis and S. aureus were the major microbial drivers of sepsis amongst cancer patients in Zimbabwe. Most isolates were found to be resistant to commonly used empirical antibiotics, with isolates exhibiting high levels of ESBL and methicillin resistance carriage. A nationwide survey on microbial aetiologies of sepsis and their susceptibility patterns would assist in the guidance of effective sepsis empiric antimicrobial treatment among patients with cancer.
Literature
1.
go back to reference Torres VB, Azevedo LC, Silva UV, Caruso P, Torelly AP, Silva E, et al. Sepsis-associated outcomes in critically ill patients with malignancies. Ann Am Thorac Soc. 2015;12(8):1185–92.PubMed Torres VB, Azevedo LC, Silva UV, Caruso P, Torelly AP, Silva E, et al. Sepsis-associated outcomes in critically ill patients with malignancies. Ann Am Thorac Soc. 2015;12(8):1185–92.PubMed
2.
go back to reference Danai PA, Moss M, Mannino DM, Martin GS. The epidemiology of sepsis in patients with malignancy*. Chest. 2006 Jun 1;129(6):1432–40.CrossRef Danai PA, Moss M, Mannino DM, Martin GS. The epidemiology of sepsis in patients with malignancy*. Chest. 2006 Jun 1;129(6):1432–40.CrossRef
3.
go back to reference Vincent J-L, Marshall JC, Ñamendys-Silva SA, François B, Martin-Loeches I, Lipman J, et al. Assessment of the worldwide burden of critical illness: the intensive care over nations (ICON) audit. Lancet Respir Med. 2014;2(5):380–6.CrossRef Vincent J-L, Marshall JC, Ñamendys-Silva SA, François B, Martin-Loeches I, Lipman J, et al. Assessment of the worldwide burden of critical illness: the intensive care over nations (ICON) audit. Lancet Respir Med. 2014;2(5):380–6.CrossRef
4.
go back to reference Williams MD, Braun LA, Cooper LM, Johnston J, Weiss RV, Qualy RL, et al. Hospitalized cancer patients with severe sepsis: analysis of incidence, mortality, and associated costs of care. Crit Care. 2004;8(5):1.CrossRef Williams MD, Braun LA, Cooper LM, Johnston J, Weiss RV, Qualy RL, et al. Hospitalized cancer patients with severe sepsis: analysis of incidence, mortality, and associated costs of care. Crit Care. 2004;8(5):1.CrossRef
5.
go back to reference Dellinger RP, Levy MM, Rhodes A, Annane D, Gerlach H, Opal SM, et al. Surviving Sepsis campaign: international guidelines for Management of Severe Sepsis and Septic Shock, 2012. Intensive Care Med. 2013;39(2):165–228.CrossRef Dellinger RP, Levy MM, Rhodes A, Annane D, Gerlach H, Opal SM, et al. Surviving Sepsis campaign: international guidelines for Management of Severe Sepsis and Septic Shock, 2012. Intensive Care Med. 2013;39(2):165–228.CrossRef
6.
go back to reference Mayr FB, Yende S, Angus DC. Epidemiology of severe sepsis. Virulence. 2014;5(1):4–11.CrossRef Mayr FB, Yende S, Angus DC. Epidemiology of severe sepsis. Virulence. 2014;5(1):4–11.CrossRef
7.
go back to reference Wisplinghoff H, Seifert H, Wenzel RP, Edmond MB. Current trends in the epidemiology of nosocomial bloodstream infections in patients with haematological malignancies and solid neoplasms in hospitals in the United States. Clin Infect Dis. 2003;36(9):1103–10.CrossRef Wisplinghoff H, Seifert H, Wenzel RP, Edmond MB. Current trends in the epidemiology of nosocomial bloodstream infections in patients with haematological malignancies and solid neoplasms in hospitals in the United States. Clin Infect Dis. 2003;36(9):1103–10.CrossRef
8.
go back to reference Lever A, Mackenzie I. Sepsis: definition, epidemiology, and diagnosis. Br Med J. 2007 Oct 25;335(7625):879–83.CrossRef Lever A, Mackenzie I. Sepsis: definition, epidemiology, and diagnosis. Br Med J. 2007 Oct 25;335(7625):879–83.CrossRef
9.
go back to reference National Medicine and Therapeutics Policy Advisory Committee (Zimbabwe). EDLIZ 2015: 7th essential medicines list and standard treatment guidelines for Zimbabwe [internet]. National Medicine and Therapeutics Policy Advisory Committee; 2015. Available from: https://books.google.co.zw/books?id=yFaOswEACAAJ. Accessed 9 Feb 2017. National Medicine and Therapeutics Policy Advisory Committee (Zimbabwe). EDLIZ 2015: 7th essential medicines list and standard treatment guidelines for Zimbabwe [internet]. National Medicine and Therapeutics Policy Advisory Committee; 2015. Available from: https://​books.​google.​co.​zw/​books?​id=​yFaOswEACAAJ. Accessed 9 Feb 2017.
10.
go back to reference Elseed YHAEA, Ibrahim MA, Ahmed WAM. Isolation and identification of aerobic bacterial pathogens from Septicaemic Cancer patients in Khartoum. Sudan Clin Med. 2015;1(4):122–5. Elseed YHAEA, Ibrahim MA, Ahmed WAM. Isolation and identification of aerobic bacterial pathogens from Septicaemic Cancer patients in Khartoum. Sudan Clin Med. 2015;1(4):122–5.
11.
go back to reference Awoniyi DO, Udo SJ, Oguntibeju OO. An epidemiological survey of neonatal sepsis in a hospital in western Nigeria. Afr J Microbiol Res. 2009;3(7):385–9. Awoniyi DO, Udo SJ, Oguntibeju OO. An epidemiological survey of neonatal sepsis in a hospital in western Nigeria. Afr J Microbiol Res. 2009;3(7):385–9.
12.
go back to reference Singer M, Deutschman CS, Seymour CW, Shankar-Hari M, Annane D, Bauer M, et al. The third international consensus definitions for sepsis and septic shock (Sepsis-3). J Am Med Assoc. 2016;315(8):801–10.CrossRef Singer M, Deutschman CS, Seymour CW, Shankar-Hari M, Annane D, Bauer M, et al. The third international consensus definitions for sepsis and septic shock (Sepsis-3). J Am Med Assoc. 2016;315(8):801–10.CrossRef
14.
go back to reference Taccone FS, Artigas AA, Sprung CL, Moreno R, Sakr Y, Vincent J-L. Characteristics and outcomes of cancer patients in European ICUs. Crit Care. 2009;13:R15.CrossRef Taccone FS, Artigas AA, Sprung CL, Moreno R, Sakr Y, Vincent J-L. Characteristics and outcomes of cancer patients in European ICUs. Crit Care. 2009;13:R15.CrossRef
15.
go back to reference El-Mahallawy H, Sidhom I, El-Din NHA, Zamzam M, El-Lamie MM. Clinical and microbiologic determinants of serious bloodstream infections in Egyptian pediatric cancer patients: a one-year study. Int J Infect Dis. 2005;9(1):43–51.CrossRef El-Mahallawy H, Sidhom I, El-Din NHA, Zamzam M, El-Lamie MM. Clinical and microbiologic determinants of serious bloodstream infections in Egyptian pediatric cancer patients: a one-year study. Int J Infect Dis. 2005;9(1):43–51.CrossRef
16.
go back to reference Wang S-S, Lee N-Y, Hsueh P-R, Huang W-H, Tsui K-C, Lee H-C, et al. Clinical manifestations and prognostic factors in cancer patients with bacteremia due to extended-spectrum β-lactamase-producing Escherichia coli or Klebsiella pneumoniae. J Microbiol Immunol Infect. 2011;44(4):282–8.CrossRef Wang S-S, Lee N-Y, Hsueh P-R, Huang W-H, Tsui K-C, Lee H-C, et al. Clinical manifestations and prognostic factors in cancer patients with bacteremia due to extended-spectrum β-lactamase-producing Escherichia coli or Klebsiella pneumoniae. J Microbiol Immunol Infect. 2011;44(4):282–8.CrossRef
17.
go back to reference Prakash KP, Arora V, Geethanjali PP. Bloodstream bacterial pathogens and their antibiotic resistance pattern in Dhahira region. Oman Oman Medical Journal. 2011;26:240–79. Prakash KP, Arora V, Geethanjali PP. Bloodstream bacterial pathogens and their antibiotic resistance pattern in Dhahira region. Oman Oman Medical Journal. 2011;26:240–79.
18.
go back to reference Mikulska M, Viscoli C, Orasch C, Livermore DM, Averbuch D, Cordonnier C, et al. Aetiology and resistance in bacteraemias among adult and paediatric haematology and cancer patients. J Infect. 2014 Apr;68(4):321–31.CrossRef Mikulska M, Viscoli C, Orasch C, Livermore DM, Averbuch D, Cordonnier C, et al. Aetiology and resistance in bacteraemias among adult and paediatric haematology and cancer patients. J Infect. 2014 Apr;68(4):321–31.CrossRef
19.
go back to reference Mikulska M, Del Bono V, Raiola AM, Bruno B, Gualandi F, Occhini D, et al. Blood stream infections in allogeneic hematopoietic stem cell transplant recipients: re-emergence of gram-negative rods and increasing antibiotic resistance. Biol Blood Marrow Transplant. 2009;15(1):47–53.CrossRef Mikulska M, Del Bono V, Raiola AM, Bruno B, Gualandi F, Occhini D, et al. Blood stream infections in allogeneic hematopoietic stem cell transplant recipients: re-emergence of gram-negative rods and increasing antibiotic resistance. Biol Blood Marrow Transplant. 2009;15(1):47–53.CrossRef
20.
go back to reference Musiime V, Cook A, Bakeera-Kitaka S, Vhembo T, Lutakome J, Keishanyu R, Prendergast AJ, Lubwama S, Robertson V, Hughes P, Nathoo K. Bacteremia, causative agents and antimicrobial susceptibility among HIV-1–infected children on antiretroviral therapy in Uganda and Zimbabwe. Pediatr Infect Dis J. 2013;32(8):856-62. Musiime V, Cook A, Bakeera-Kitaka S, Vhembo T, Lutakome J, Keishanyu R, Prendergast AJ, Lubwama S, Robertson V, Hughes P, Nathoo K. Bacteremia, causative agents and antimicrobial susceptibility among HIV-1–infected children on antiretroviral therapy in Uganda and Zimbabwe. Pediatr Infect Dis J. 2013;32(8):856-62.
21.
go back to reference Yang Q, Zhang H, Wang Y, Xu Y, Chen M, Badal RE, et al. A 10 year surveillance for antimicrobial susceptibility of Escherichia coli and Klebsiella pneumoniae in community-and hospital-associated intra-abdominal infections in China. J Med Microbiol. 2013;62(9):1343–9.CrossRef Yang Q, Zhang H, Wang Y, Xu Y, Chen M, Badal RE, et al. A 10 year surveillance for antimicrobial susceptibility of Escherichia coli and Klebsiella pneumoniae in community-and hospital-associated intra-abdominal infections in China. J Med Microbiol. 2013;62(9):1343–9.CrossRef
22.
go back to reference Alabi AS, Frielinghaus L, Kaba H, Kösters K, Huson MAM, Kahl BC, et al. Retrospective analysis of antimicrobial resistance and bacterial spectrum of infection in Gabon. Cent Afr BMC Infect Dis. 2013;13:455.CrossRef Alabi AS, Frielinghaus L, Kaba H, Kösters K, Huson MAM, Kahl BC, et al. Retrospective analysis of antimicrobial resistance and bacterial spectrum of infection in Gabon. Cent Afr BMC Infect Dis. 2013;13:455.CrossRef
23.
go back to reference Gudiol C, Bodro M, Simonetti A, Tubau F, González-Barca E, Cisnal M, et al. Changing aetiology, clinical features, antimicrobial resistance, and outcomes of bloodstream infection in neutropenic cancer patients. Clin Microbiol Infect. 2013;19(5):474–9.CrossRef Gudiol C, Bodro M, Simonetti A, Tubau F, González-Barca E, Cisnal M, et al. Changing aetiology, clinical features, antimicrobial resistance, and outcomes of bloodstream infection in neutropenic cancer patients. Clin Microbiol Infect. 2013;19(5):474–9.CrossRef
24.
go back to reference Acquah SE, Quaye L, Sagoe K, Ziem JB, Bromberger PI, Amponsem AA. Susceptibility of bacterial etiological agents to commonly-used antimicrobial agents in children with sepsis at the tamale teaching hospital. BMC Infect Dis. 2013;13:89.CrossRef Acquah SE, Quaye L, Sagoe K, Ziem JB, Bromberger PI, Amponsem AA. Susceptibility of bacterial etiological agents to commonly-used antimicrobial agents in children with sepsis at the tamale teaching hospital. BMC Infect Dis. 2013;13:89.CrossRef
25.
go back to reference Sharma CM, Agrawal RP, Sharan H, Kumar B, Sharma D, Bhatia SS. “Neonatal Sepsis”: Bacteria & their Susceptibility Pattern towards Antibiotics in Neonatal Intensive Care Unit. J Clin Diagn Res: JCDR. 2013;7(11):2511.PubMed Sharma CM, Agrawal RP, Sharan H, Kumar B, Sharma D, Bhatia SS. “Neonatal Sepsis”: Bacteria & their Susceptibility Pattern towards Antibiotics in Neonatal Intensive Care Unit. J Clin Diagn Res: JCDR. 2013;7(11):2511.PubMed
26.
go back to reference Prabhash K, Medhekar A, Ghadyalpatil N, Noronha V, Biswas S, Kurkure P, et al. Blood stream infections in cancer patients: a single center experience of isolates and sensitivity pattern. Indian J Cancer. 2010 Apr 1;47(2):184.CrossRef Prabhash K, Medhekar A, Ghadyalpatil N, Noronha V, Biswas S, Kurkure P, et al. Blood stream infections in cancer patients: a single center experience of isolates and sensitivity pattern. Indian J Cancer. 2010 Apr 1;47(2):184.CrossRef
27.
go back to reference Poyart C, Pierre C, Quesne G, Pron B, Berche P, Trieu-Cuot P. Emergence of vancomycin resistance in the genus Streptococcus: characterization of a vanB transferable determinant in Streptococcus bovis. Antimicrob Agents Chemother. 1997;41(1):24–9.CrossRef Poyart C, Pierre C, Quesne G, Pron B, Berche P, Trieu-Cuot P. Emergence of vancomycin resistance in the genus Streptococcus: characterization of a vanB transferable determinant in Streptococcus bovis. Antimicrob Agents Chemother. 1997;41(1):24–9.CrossRef
28.
go back to reference Gudiol C, Tubau F, Calatayud L, Garcia-Vidal C, Cisnal M, Sánchez-Ortega I, et al. Bacteraemia due to multidrug-resistant gram-negative bacilli in cancer patients: risk factors, antibiotic therapy and outcomes. J Antimicrob Chemother. 2011;66(3):657–63.CrossRef Gudiol C, Tubau F, Calatayud L, Garcia-Vidal C, Cisnal M, Sánchez-Ortega I, et al. Bacteraemia due to multidrug-resistant gram-negative bacilli in cancer patients: risk factors, antibiotic therapy and outcomes. J Antimicrob Chemother. 2011;66(3):657–63.CrossRef
Metadata
Title
Sepsis in cancer patients residing in Zimbabwe: spectrum of bacterial and fungal aetiologies and their antimicrobial susceptibility patterns
Authors
Frank Chinowaita
Wendy Chaka
Tinashe K. Nyazika
Tendai C. Maboreke
Emmanuel Tizauone
Prichard Mapondera
Inam Chitsike
Andrew Z. Cakana
Rooyen T. Mavenyengwa
Publication date
01-12-2020
Publisher
BioMed Central
Published in
BMC Infectious Diseases / Issue 1/2020
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/s12879-020-4886-2

Other articles of this Issue 1/2020

BMC Infectious Diseases 1/2020 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.